menu
    • menu

    Find Icosapent Ethyl manufacturers, exporters & distributors on PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    30

    API Suppliers

    API Suppliers

    25

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    8

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    1

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    8

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 219

    MARKET PLACE

    21

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    29

    FDF Dossiers

    FDF Dossiers

    19

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    1

    Canada

    Canada

    1

    Australia

    Australia

    0

    South Africa

    South Africa

    6

    Listed Dossiers

    Listed Dossiers

    49DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    1

    EDQM

    1

    USP

    2

    JP

    2

    Others

    PATENTS & EXCLUSIVITIES

    129

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    155

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    172,833,408

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    86 RELATED EXCIPIENT COMPANIES

    144EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, Epa, Cis-5,8,11,14,17-eicosapentaenoic acid
    Molecular Formula
    C20H30O2
    Molecular Weight
    302.5  g/mol
    InChI Key
    JAZBEHYOTPTENJ-JLNKQSITSA-N
    FDA UNII
    AAN7QOV9EA
    Icosapent Ethyl
    Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
    1 2D Structure

    Icosapent Ethyl

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
    2.1.2 InChI
    InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-
    2.1.3 InChI Key
    JAZBEHYOTPTENJ-JLNKQSITSA-N
    2.1.4 Canonical SMILES
    CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
    2.1.5 Isomeric SMILES
    CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    AAN7QOV9EA
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5,8,11,14,17-eicosapentaenoic Acid

    2. 5,8,11,14,17-icosapentaenoic Acid

    3. Acid, Eicosapentanoic

    4. Eicosapentanoic Acid

    5. Icosapent

    6. Omega 3 Eicosapentaenoic Acid

    7. Omega-3-eicosapentaenoic Acid

    8. Timnodonic Acid

    2.3.2 Depositor-Supplied Synonyms

    1. Timnodonic Acid

    2. Icosapent

    3. 10417-94-4

    4. Icosapentaenoic Acid

    5. Epa

    6. Cis-5,8,11,14,17-eicosapentaenoic Acid

    7. (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

    8. Icosapento

    9. Icosapentum

    10. 5,8,11,14,17-eicosapentaenoic Acid

    11. Eicosapentaenoate

    12. 5z,8z,11z,14z,17z-eicosapentaenoic Acid

    13. (all-z)-5,8,11,14,17-eicosapentaenoic Acid

    14. Icosapent [inn]

    15. (5z,8z,11z,14z,17z)-5,8,11,14,17-eicosapentaenoic Acid

    16. 5,8,11,14,17-icosapentaenoic Acid

    17. Ropufa 70

    18. Ccris 3279

    19. Incromega E 7010sr

    20. Aan7qov9ea

    21. (5z,8z,11z,14z,17z)-icosapentaenoic Acid

    22. (5z,8z,11z,14z,17z)-eicosapentaenoic Acid

    23. Omega-3-carboxylic Acids

    24. Epa 45g

    25. Chembl460026

    26. (5z,8z,11z,14z,17z)-eicosapentaenoate

    27. All-cis-5,8,11,14,17-icosapentaenoic Acid

    28. Chebi:28364

    29. All-cis-5,8,11,14,17-eicosapentaenoic Acid

    30. All-cis-icosa-5,8,11,14,17-pentaenoic Acid

    31. Icosapent (inn)

    32. Cis-delta(5,8,11,14,17)-eicosapentaenoic Acid

    33. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)-

    34. All-cis-fatty Acid 20:5 Omega-3

    35. Eicosapentaenoic Acid (c20:5 N3)

    36. Epa;timnodonic Acid

    37. Icosapentaenoate

    38. (all-z)-delta5,8,11,14,17-eicosapentaenoic Acid

    39. C20:5n-3,6,9,12,15

    40. Cis-5,8,11,14,17-epa

    41. Fa 20:5

    42. Ncgc00161344-03

    43. C20:5 (n-3)

    44. Eicosapentaenoic Acid (20:5 N-3)

    45. Eicosa-5z,8z,11z,14z,17z-pentaenoic Acid (20:5, N-3)

    46. Miraxion

    47. Eicosapentanoic Acid

    48. Eye Q

    49. Eye-q

    50. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)-

    51. Epa [drug]

    52. Unii-aan7qov9ea

    53. 1553-41-9

    54. Icosapentum [inn-latin]

    55. Icosapento [inn-spanish]

    56. (5z,8z,11z,14z,17z)-icosapentaenoate

    57. Timnodonate

    58. 3gwx

    59. All Cis-5,8,11,14,17-eicosapentaenoic Acid

    60. Mfcd00065716

    61. All-cis-icosapentaenoate

    62. All-cis-icosapentaenoic Acid

    63. Dsstox_cid_21023

    64. Dsstox_rid_79612

    65. Dsstox_gsid_41023

    66. Schembl20469

    67. Bspbio_001328

    68. Bml3-b01

    69. Gtpl3362

    70. Dtxsid9041023

    71. Eicosapentaenoic Acid [mi]

    72. Hms1361c10

    73. Hms1791c10

    74. Hms1989c10

    75. Hms3402c10

    76. Hms3649d19

    77. Hy-b0660

    78. Zinc4474603

    79. 5,8,11,14,17-icosapentaenoate

    80. Eicosapentaenoic Acid [inci]

    81. Tox21_111991

    82. 5,8,11,14,17-eicosapentaenoate

    83. Bdbm50242349

    84. Eicosapentaenoic Acid [vandf]

    85. Lmfa01030759

    86. S6476

    87. Eicosapentaenoic Acid [mart.]

    88. Akos027470327

    89. Eicosapentaenoic Acid [usp-rs]

    90. Eicosapentaenoic Acid [who-dd]

    91. Ccg-207957

    92. Ccg-208136

    93. Db00159

    94. Cis-5,8,11,14,17-eicosapentaenoate

    95. Idi1_033798

    96. Ncgc00161344-01

    97. Ncgc00161344-02

    98. Ncgc00161344-04

    99. Ncgc00161344-07

    100. 5z,8z,11z,14z,17z-eicosapentaenoate

    101. Ac-31072

    102. As-53730

    103. Cas-10417-94-4

    104. E0441

    105. 5,8,11,14,17-eicosapentaenoic Acid (6ci)

    106. All Cis-5,8,11,14,17-icosapentaenoic Acid

    107. C06428

    108. D08061

    109. P16966

    110. (all-cis)-5,8,11,14,17-eicosapentaenoic Acid

    111. Eicosapentaenoic Acid (epa) (c20:5 N3)

    112. L001256

    113. Q409990

    114. Sr-01000946647

    115. Fa(20:5(5z,8z,11z,14z,17z))

    116. J-001125

    117. Sr-01000946647-1

    118. Z,z,z,z,z-eicosa-5,8,11,14,17-pentaenoic Acid

    119. (z,z,z,z,z)-5,8,11,14,17-eicosapentaenoic Acid

    120. Brd-k47192521-001-02-1

    121. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=99%

    122. 7f8bf016-b146-4f72-a52e-b9298ba3a9ab

    123. C20h30o2 (cis-5,8,11,14,17-eicosapentaenoic Acid)

    124. Eicosapentaenoic Acid, 5,8,11,14,17-(z,z,z,z,z)-

    125. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)- (8ci)

    126. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=85%, Liquid

    127. Cis-5,8,11,14,17-eicosapentaenoic Acid, Analytical Standard

    128. (5z,8z,11 Z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

    129. (5z,8z,11z,14z,17z)-eicosa-5,8,11,14,17-pentaenoic Acid

    130. Cis, Cis, Cis, Cis, Cis-eicosa-5,8,11,14,17-pentaenoic Acid

    131. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)- (9ci)

    132. Eicosapentaenoic Acid (epa) (c20:5) (constituent Of Krill Oil) [dsc]

    133. Cis-5,8,11,14,17-eicosapentaenoic Acid, 500 Mug/ml In Ethanol, Certified Reference Material

    2.4 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 302.5 g/mol
    Molecular Formula C20H30O2
    XLogP35.6
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count13
    Exact Mass302.224580195 g/mol
    Monoisotopic Mass302.224580195 g/mol
    Topological Polar Surface Area37.3 Ų
    Heavy Atom Count22
    Formal Charge0
    Complexity398
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count5
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy.

    FDA Label

    OM3-CA is indicated as an adjunct to diet to reduce triglycerides levels in adults patients with severe hypertriglyceridemia (>500 mg/dL). The patients involved in this treatment should be laced with an appropriate lipid-lowering diet. Hypertriglyceridemia is defined as an elevated plasma triglyceride concentration. It is usually correlated to other secondary conditions such as poor diet, alcohol use, obesity, metabolic syndrome and type 2 diabetes.

    FDA Label

    Treatment of Familial Adenomatous Polyposis

    Treatment of dyslipidaemia

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Eicosanoids are chemical messengers derived from 20-carbon polyunsaturated fatty acids that play critical roles in immune and inflammatory responses. Both 20-carbon omega-6 fatty acids (arachidonic acid) and 20-carbon omega-3 fatty acids (EPA) can be found in cell membranes. During an inflammatory response, arachidonic acid and EPA are metabolized by enzymes known as cyclooxygenases and lipoxygenases to form eicosanoids. Increasing omega-3 fatty acid intake increases the EPA content of cell membranes and decreases the arachidonic acid content, resulting in higher proportions of eicosanoids derived from EPA. Physiologic responses to arachidonic acid-derived eicosanoids differ from responses to EPA-derived eicosanoids. In general, eicosanoids derived from EPA are less potent inducers of inflammation, blood vessel constriction, and clotting than eicosanoids derived from arachidonic acid.

    OM3-CA is very effective in reducing triglyceride levels. After 14 days of treatment, it is possible to observe even a 21% reduction. The reduction of the triglycerides could reach even to 25% in cases with the maximal used concentration of 4 g.

    5.2 Absorption, Distribution and Excretion

    Absorption

    When compared to omega-3 -acid ethyl esters, OM3-CA present a 4-fold higher bioavailability. OM3-CA is absorbed directly in the small intestine and the maximal plasma concentration is reached between 4.5-5 hours after initial administration. The absorbed dosage is transferred to the general circulation via the lymphatic system and distributed within tissues throughout the body. The absorption speed and extent is highly promoted by the bile. In preclinical studies performed in dogs, the Cmax, tmax and AUC were reported to be 15.1 mcg/ml, 24 hours and 1210.3 mcg.h/ml, respectively.

    Route of Elimination

    OM3-CA does not go under renal excretion. After the metabolism, all the dose is excreted as CO2 and water in the form of expelled air and the rest is excreted in feces.

    Volume of Distribution

    This pharmacokinetic property is not available.

    Clearance

    The registered clearance rate at steady-state is of 548 ml/h for eicosapentaenoic acid and 518 ml/h for docohexaenoic acid.

    5.3 Metabolism/Metabolites

    OM3-CA is metabolized in the liver following the normal fatty acid oxidation. Once absorbed, they are incorporated into triglycerides, cholesterol esters and phospholipids in tissues. The metabolism is marked by beta-oxidation followed by tricarboxylic acid cycle. It is reported that OM3-CA is an inhibitor of several enzymes such as CYP2C9, CYP2C19 and to a lesser extent to CYP1A2, CYP2E1, CYP3A4. It is thought that the metabolism of OM3-CA is mainly done by CYP3A and CYP4F3B.

    Eicosapentaenoic acid has known human metabolites that include Juniperonic acid.

    S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

    5.4 Biological Half-Life

    The half-life of OM3-CA depends on the type of component in which for eicosapentaenoic acid it is estimated to be of approximately 4.7-10.8 hours while for docosahexaenoic acid is reported to be of about 7 hours. The half-life of baseline-adjusted at steady-state is of 36 and 46 hours respectively for eicosapentaenoic acid and docosahexaenoic acid.

    5.5 Mechanism of Action

    The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.

    The reduction of the synthesis of triglycerides in the liver may be caused because the main components of OM3-CA, eicosapentaenoic acid, and docosahexaenoic acid, are poor substrates for the enzymes responsible for the synthesis of triglycerides. These two major components inhibit the esterification of other fatty acids. OM3-CA is also thought to enhance the clearance of triglycerides from the circulating very low-density lipoprotein particles by different potential effects such as inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increase in mitochondrial and peroxisomal beta-oxidation in the liver, decrease lipogenesis in the liver and increase lipoprotein lipase activity.

    API SUPPLIERS

    read-more
    read-more

    01

    Axplora

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAxplora- The partner of choice for complex APIs.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-06-07

    Pay. Date : 2023-06-05

    DMF Number : 27182

    Submission : 2013-05-23

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Axplora CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DKSH

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    DKSH Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Chunghwa Chemical Synthesis & Biot...

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-04-01

    Pay. Date : 2012-11-20

    DMF Number : 26271

    Submission : 2012-08-01

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    CCSB Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    KinOmega Biopharm Inc.

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    KinOmega Biopharm Inc.

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39040

    Submission : 2023-10-25

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NISSHIN PHARMA INC

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    NISSHIN PHARMA INC

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15062

    Submission : 2000-09-29

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    BASF

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    BASF

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2020-11-02

    Pay. Date : 2020-10-20

    DMF Number : 23911

    Submission : 2010-07-07

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 223MF10118

    Registrant's Address : 4th and 5th Floors, 2 Stockport Exchange, Railway Road, Stockport, SK1 3GG, UK

    Initial Date of Registration : 2011-07-25

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NIPPON SUISAN KAISHA LTD

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    NIPPON SUISAN KAISHA LTD

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22474

    Submission : 2009-01-23

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NIPPON SUISAN KAISHA LTD

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    NIPPON SUISAN KAISHA LTD

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 34019

    Submission : 2019-09-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    AK AND MN BIOFARM CO LTD

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    AK AND MN BIOFARM CO LTD

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27998

    Submission : 2014-02-10

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    KinOmega Biopharm Inc.

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmScience R&D
    Not Confirmed
    arrow

    KinOmega Biopharm Inc.

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmScience R&D
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37763

    Submission : 2022-12-11

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Finorga Sas

    Germany
    arrow
    PharmScience R&D
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAxplora- The partner of choice for complex APIs.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2023-06-07

    Pay. Date : 2023-06-05

    DMF Number : 27182

    Submission : 2013-05-23

    Status : Active

    Type : II

    Axplora CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Chunghwa Chemical Synthesis And Biot...

    Taiwan
    arrow
    PharmScience R&D
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-04-01

    Pay. Date : 2012-11-20

    DMF Number : 26271

    Submission : 2012-08-01

    Status : Active

    Type : II

    CCSB Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Ak Biopharm Co Ltd

    South Korea

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    03

    Ak Biopharm Co Ltd

    South Korea
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26946

    Submission : 2013-03-04

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Ak And Mn Biofarm Co Ltd

    South Korea

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    04

    Ak And Mn Biofarm Co Ltd

    South Korea
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27998

    Submission : 2014-02-10

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Basf As

    Germany

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    05

    Basf As

    Germany
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2020-11-02

    Pay. Date : 2020-10-20

    DMF Number : 23911

    Submission : 2010-07-07

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    PharmScience R&D
    Not Confirmed

    06

    Catalent Pharma Solutions Llc

    U.S.A
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25289

    Submission : 2011-09-12

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Chemport Inc

    United Kingdom

    USDMF

    arrow
    BioAsia
    Not Confirmed

    07

    Chemport Inc

    United Kingdom
    arrow
    BioAsia
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22077

    Submission : 2008-10-09

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Kd Pharma Bexbach Gmbh

    Germany

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    08

    Kd Pharma Bexbach Gmbh

    Germany
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-02-20

    Pay. Date : 2014-04-09

    DMF Number : 28140

    Submission : 2014-03-31

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Kd Pharma Bexbach Gmbh

    Germany

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    09

    Kd Pharma Bexbach Gmbh

    Germany
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-08-21

    Pay. Date : 2013-02-27

    DMF Number : 26892

    Submission : 2013-02-26

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Nissui Corporation

    Japan

    USDMF

    arrow
    PharmScience R&D
    Not Confirmed

    10

    Nissui Corporation

    Japan
    arrow
    PharmScience R&D
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22474

    Submission : 2009-01-23

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    AK BIOPHARM CO. , LTD.

    South Korea
    The Generic Rx Session
    Not Confirmed
    arrow

    AK BIOPHARM CO. , LTD.

    South Korea
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AK&MN Biofarm Eicosapentate (raw material) (for export)

    Registration Number : 227MF10010

    Registrant's Address : #81, Sanggae-Ro, Nam-Gu, Ulsan, Korea

    Initial Date of Registration : 2015-01-05

    Latest Date of Registration : 2015-01-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    BASF Pharma (Callanish) Ltd.

    Germany
    The Generic Rx Session
    Not Confirmed
    arrow

    BASF Pharma (Callanish) Ltd.

    Germany
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Maxomega EPA 97EE

    Registration Number : 223MF10118

    Registrant's Address : 4th and 5th Floors, 2 Stockport Exchange, Railway Road, Stockport, SK1 3GG, UK

    Initial Date of Registration : 2011-07-25

    Latest Date of Registration : 2016-12-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bizen Chemical Co., Ltd.

    Japan
    The Generic Rx Session
    Not Confirmed
    arrow

    Bizen Chemical Co., Ltd.

    Japan
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapentosan EQ

    Registration Number : 217MF10441

    Registrant's Address : 363 Tokutomi, Akaiwa City, Okayama Prefecture

    Initial Date of Registration : 2005-08-19

    Latest Date of Registration : 2020-06-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Chemport Inc.

    United Kingdom
    The Generic Rx Session
    Not Confirmed
    arrow

    Chemport Inc.

    United Kingdom
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl icosapentate

    Registration Number : 227MF10158

    Registrant's Address : 30-5 Dongsunonggongdanji-gil, Naju-si, Jeollanam-do 58275, Korea

    Initial Date of Registration : 2015-06-18

    Latest Date of Registration : 2016-07-15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Huatai Pharma Inc.

    China
    The Generic Rx Session
    Not Confirmed
    arrow

    Huatai Pharma Inc.

    China
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl icosapentate

    Registration Number : 303MF10106

    Registrant's Address : No. 37 Section 6, North Chengdu Avenue, Guanghan, Deyang City, Sichuan Province P. R....

    Initial Date of Registration : 2021-07-09

    Latest Date of Registration : 2023-08-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    K. D. Pharma Bexbach GmbH

    Germany
    The Generic Rx Session
    Not Confirmed
    arrow

    K. D. Pharma Bexbach GmbH

    Germany
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl icosapentate

    Registration Number : 228MF10081

    Registrant's Address : Am Kraftwerk 6,66450 Bexbach, Germany

    Initial Date of Registration : 2016-04-06

    Latest Date of Registration : 2016-04-06

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    K. D. Pharma Bexbach GmbH

    Switzerland
    The Generic Rx Session
    Not Confirmed
    arrow

    K. D. Pharma Bexbach GmbH

    Switzerland
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl icosapentate

    Registration Number : 303MF10048

    Registrant's Address : Am Kraftwerk 6,66450 Bexbach, Germany

    Initial Date of Registration : 2021-03-17

    Latest Date of Registration : 2021-03-17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Shandong Xinhua Pharmaceutical Co. ...

    China
    The Generic Rx Session
    Not Confirmed
    arrow

    Shandong Xinhua Pharmaceutical Co. ...

    China
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ETHYL ICO SAPENTATE

    Registration Number : 305MF10044

    Registrant's Address : No. 1, Lutai Road, High-tech District, Zibo, Shandong, P. R. China

    Initial Date of Registration : 2023-04-05

    Latest Date of Registration : 2023-04-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Chemport Inc

    United Kingdom
    The Generic Rx Session
    Not Confirmed
    arrow

    Chemport Inc

    United Kingdom
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl icosapentate

    Registrant Name : Kemport Co., Ltd.

    Registration Date : 2022-08-22

    Registration Number : 20220822-211-J-1348

    Manufacturer Name : Kemport Co., Ltd.

    Manufacturer Address : Laboratory: 2nd floor, Research Building, 52, Goha-daero 719beongil, Mokpo-si, Jeolla...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Axplora

    Germany
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAxplora- The partner of choice for complex APIs.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...

    Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.
    Axplora CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Chunghwa Chemical Synthesis & Biote...

    Taiwan
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Eicosapentaenoic Acid

    About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast...

    Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.
    CCSB Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Chunghwa Chemical Synthesis & Biote...

    Taiwan
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast...

    Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.
    CCSB Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    BASF

    Germany
    BioAsia
    Not Confirmed
    arrow

    BASF

    Germany
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EICOSAPENTAENOIC ACID ETHYL ESTER (EPA-E)

    About the Company : We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and alm...

    We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of approximately €6.7 billion. We combine economic success with environmental protection and social responsibility. Through research and innovation, we support our customers in nearly every industry.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Royal DSM

    Netherlands
    BioAsia
    Not Confirmed
    arrow

    Royal DSM

    Netherlands
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Netherlands
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal...

    Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal is to develop health and nutrition solutions that are scientifically sound. Royal DSM's products and solutions address some of the world's most pressing issues while also adding economic, environmental and societal value to all stakeholders. More than 2.5 billion people worldwide use the company's solutions. Royal DSM and its affiliated companies employ approximately 23,000 people worldwide and generate around €10 billion in net sales per year.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Sichuan Gowell Pharmaceutical

    China
    BioAsia
    Not Confirmed
    arrow

    Sichuan Gowell Pharmaceutical

    China
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Ph...

    Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Pharmaceutical Co., Ltd., and Shanghai Ocuen Biotechnology Co., Ltd. After years of development, Guowei Pharmaceutical has developed into a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. Guowei Pharmaceutical's research and development and sales of products are mainly concentrated in the fields of cardiovascular and cerebrovascular, digestive system, anti-infection, and urinary system.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Zenfold Sustainable Technologies

    India
    BioAsia
    Not Confirmed
    arrow

    Zenfold Sustainable Technologies

    India
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Icosapent Ethyl

    About the Company : Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure a...

    Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure allow us to provide the entire gamut of services involved in manufacturing and contract research — from process development to scaling up. We offer a wide range of APIs and intermediates to customers across industries. We differentiate ourselves in the market with our unique hybridized approach to manufacturing, built on our three core technological platforms: Synthetic Biology, Biotransformation, and Green Chemistry.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633631400,"product":"PHARMACEUTICAL RAW MATERIAL ICOSAPENT ET","address":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"MARPHARIND","customerCountry":"EGYPT","quantity":"600.00","actualQuantity":"600","unit":"KGS","unitRateFc":"294.5","totalValueFC":"170373.3","currency":"USD","unitRateINR":21271.666666666668,"date":"08-Oct-2021","totalValueINR":"12763000","totalValueInUsd":"170373.3","indian_port":"BOMBAY AIR","hs_no":"29161990","bill_no":"5169978","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648060200,"product":"PHARMACEUTICAL RAW MATERIAL ICOSAPENT ET","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ALEXANDRIA, EL NHOUZ","customer":"LIFOPHMEPR","customerCountry":"EGYPT","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"400","totalValueFC":"669.1","currency":"USD","unitRateINR":25500,"date":"24-Mar-2022","totalValueINR":"51000","totalValueInUsd":"669.1","indian_port":"BOMBAY AIR","hs_no":"29161990","bill_no":"9179883","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1610649000,"product":"ETHYL ICOSAPENTATE","address":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"FLAVINE","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"600","totalValueFC":"15177","currency":"USD","unitRateINR":"44400","date":"15-Jan-2021","totalValueINR":"1110000","totalValueInUsd":"15177","indian_port":"HYDERABAD AIR","hs_no":"29159099","bill_no":"2367922","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"ICOSAPENT ETHYL","year":"2021","qtr":"Q1","strtotime":1617042600,"product":"ICOSAPENT ETHYL (FOR TESTING PURPOSE ONLY)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"","customer":"CIPLA","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"186","totalValueFC":"562.2","currency":"USD","unitRateINR":"13643.1","date":"30-Mar-2021","totalValueINR":"40929.3","totalValueInUsd":"562.2","indian_port":"BOMBAY AIR","hs_no":"29161950","bill_no":"3358153","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632076200,"product":"ICOSAPENT ETHYL(BATCH NO: EPA97-210601, EPA97-210602)(QTY 90.2 KGS, USD 14702.60)","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"90.20","actualQuantity":"90.2","unit":"KGS","unitRateFc":"163","totalValueFC":"14871.2","currency":"USD","unitRateINR":"12127.2","date":"20-Sep-2021","totalValueINR":"1093873.44","totalValueInUsd":"14871.2","indian_port":"BANGALORE AIR","hs_no":"29349990","bill_no":"5517305","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"7-1-27, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645727400,"product":"ICOSAPENT ETHYL","address":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"FLAVINE","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MS APL HEALTH ","customerCountry":"INDIA","quantity":"320.00","actualQuantity":"320","unit":"KGS","unitRateFc":"585","totalValueFC":"189929.9","currency":"USD","unitRateINR":"44489.3","date":"25-Feb-2022","totalValueINR":"14236560","totalValueInUsd":"189929.9","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29159099","bill_no":"1000318","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"10 REUTEN DRIVE CLOSTER, NEW JERSEY, 07624 USA US","customerAddress":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656181800,"product":"ICOSAPENT ETHYL","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"AK & MN BIOFARM","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"250","totalValueFC":"1265","currency":"USD","unitRateINR":"19737.5","date":"26-Jun-2022","totalValueINR":"98687.5","totalValueInUsd":"1265","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9286278","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665513000,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"350","totalValueFC":"85","currency":"USD","unitRateINR":"34953.7","date":"12-Oct-2022","totalValueINR":"6990.73","totalValueInUsd":"85","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"2837024","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673893800,"product":"MAXOMEGA TM EPA 96 EE 10KG ALUMINIUM BOTTLE (ICOSAPENT ETHYL)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"314.9","totalValueFC":"17599.9","currency":"USD","unitRateINR":"28779.2","date":"17-Jan-2023","totalValueINR":"1438961.8","totalValueInUsd":"17599.9","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"4229878","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675967400,"product":"ICOSAPENT ETHYL LOT. NO L003240","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"K.D. PHARMA BEXBACH GMBH","supplierCountry":"GERMANY","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"175","totalValueFC":"3506.8","currency":"USD","unitRateINR":"14481.3","date":"10-Feb-2023","totalValueINR":"289625","totalValueInUsd":"3506.8","indian_port":"BOMBAY AIR","hs_no":"29161990","bill_no":"4597001","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676831400,"product":"MAXOMEGA EPA 96 EE 10 KG IP3A (ICOSAPENT ETHYL) FOR EXCIPIENT USE ONLY","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"314.9","totalValueFC":"34871","currency":"USD","unitRateINR":"28800","date":"20-Feb-2023","totalValueINR":"2880000","totalValueInUsd":"34871","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"4726813","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679855400,"product":"50356278 ICOSAPENT ETHYL(MAXOMEGA EPA 96 EE)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"190.00","actualQuantity":"190","unit":"KGS","unitRateFc":"155.5","totalValueFC":"36241.9","currency":"USD","unitRateINR":"15689","date":"27-Mar-2023","totalValueINR":"2980910.09","totalValueInUsd":"36241.9","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"5239886","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1682015400,"product":"MAXOMEGA EPA 96 EE 30 KG (ICOSAPENT ETHYL) FOR EXCIPIENT USEONLY","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"331.8","totalValueFC":"11758.1","currency":"USD","unitRateINR":"32120.7","date":"21-Apr-2023","totalValueINR":"963620.54","totalValueInUsd":"11758.1","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"5623223","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685903400,"product":"EPA 97% (ICOSAPENT ETHYL 97%)","address":"BASEMENT & GF PLOT NO-683,BLOCK-CW ,","city":"SANJAY GANDHI TRANSPORT NAGAR,DELHI","supplier":"KINOMEGA BIOPHARM INC.","supplierCountry":"CHINA","foreign_port":"NA","customer":"NUTRA ZONE","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"155","totalValueFC":"7863.5","currency":"USD","unitRateINR":"12927.3","date":"05-Jun-2023","totalValueINR":"646349.69","totalValueInUsd":"7863.5","indian_port":"BOMBAY AIR","hs_no":"29161990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"BASEMENT & GF PLOT NO-683,BLOCK-CW ,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694629800,"product":"ICOSAPENT ETHYL (FOC)","address":"206, DEVAVRATA,","city":"NAVI MUMBAI, MAHARASHTRA.","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"STRIDES PHARMA SCIENCE","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"156","totalValueFC":"79.9","currency":"USD","unitRateINR":"13262","date":"14-Sep-2023","totalValueINR":"6631.01","totalValueInUsd":"79.9","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"7836938","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.37 SECTION 6, NORTH CHENGDU AVENUE, GUANGHAN, DEYANG CITY, SICHUANPROVINCE 618304 P.R CN","customerAddress":"206, DEVAVRATA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"ETHYL ICOSAPENTATE OMEGA 3 - ORGANIC CHEMICAL","address":"NO S 26 BOMMASANDRA INDUSTRIAL ARE","city":"BANGALORE,KARNATAKA","supplier":"NOVASEP","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"ALTHERA LABORATORIES INDIA ","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"428","totalValueFC":"4676","currency":"EUR","unitRateINR":"38798.2","date":"21-Feb-2024","totalValueINR":"387982","totalValueInUsd":"4676","indian_port":"Bangalore Air","hs_no":"29161990","bill_no":"2240597","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"AVENUE DU LAC,F-64150, MOURENX,FRANCESDNF France","customerAddress":"NO S 26 BOMMASANDRA INDUSTRIAL ARE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708626600,"product":"ICOSAPENT ETHYL (FOR R&D PURPOSE ONLY)","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"NOVASEP","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"448","totalValueFC":"2447.2","currency":"EUR","unitRateINR":"40611.2","date":"23-Feb-2024","totalValueINR":"203056","totalValueInUsd":"2447.2","indian_port":"Bombay Air","hs_no":"29161990","bill_no":"2273653","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"AVENUE DU LAC, F-64150 MOURENXSDNFSDNF France","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710959400,"product":"ICOSAPENT ETHYL(EPA960EE)","address":"PLOT NO-51,MEENAKSHI BAMBOO,GACHIB","city":"HYDERABAD,TELANGANA","supplier":"NORA SAOULI","supplierCountry":"FRANCE","foreign_port":"N\/A","customer":"CRONUS PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"183.4","totalValueFC":"185.3","currency":"USD","unitRateINR":"15384","date":"21-Mar-2024","totalValueINR":"15384","totalValueInUsd":"185.3","indian_port":"GMR HYDERABAD AVIATION-SEZ","hs_no":"29161990","bill_no":"1002279","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"PLOT NO-51,MEENAKSHI BAMBOO,GACHIB"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718562600,"product":"ETHYL ICOSAPENTATE 98","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"SHANDONG XINHUA PHARMACEUTICAL CO.,LTD. NO.1,LUTAI","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"VIATRIS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"130","totalValueFC":"2625.6","currency":"USD","unitRateINR":"10959","date":"17-Jun-2024","totalValueINR":"219180","totalValueInUsd":"2625.6","indian_port":"Hyderabad Air","hs_no":"29159099","bill_no":"4038357","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"ROAD,ZIBO,SHANDONG,CHINA NO.1, LUTAI ROAD, ZIBO, SHANDONG, CHINASDNF China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719513000,"product":"ICOSAPENT ETHYL (EPA960EE)FOR TESTING PURPOSE","address":"NO.15, GOPALAKRISHNAN ROAD,","city":"CHENNAI","supplier":"CHEMPORT INC","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MADRAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.83","actualQuantity":"0.83","unit":"KGS","unitRateFc":"150","totalValueFC":"129.5","currency":"USD","unitRateINR":"13029.2","date":"28-Jun-2024","totalValueINR":"10814.26","totalValueInUsd":"129.5","indian_port":"Madras Air","hs_no":"29420090","bill_no":"4234394","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"30-5 DONGSUNONGGONGDANJI-GILJEOLLANAM NAJU-SI58275 KR KOREA,REPUBLIC OF","customerAddress":"NO.15, GOPALAKRISHNAN ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719513000,"product":"ICOSAPENT ETHYL (EPA960EE)FOR TESTING PURPOSE","address":"NO.15, GOPALAKRISHNAN ROAD,","city":"CHENNAI","supplier":"CHEMPORT INC","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MADRAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"189.00","actualQuantity":"189","unit":"KGS","unitRateFc":"150","totalValueFC":"29498.6","currency":"USD","unitRateINR":"13029.2","date":"28-Jun-2024","totalValueINR":"2462524.35","totalValueInUsd":"29498.6","indian_port":"Madras Air","hs_no":"29420090","bill_no":"4234394","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"30-5 DONGSUNONGGONGDANJI-GILJEOLLANAM NAJU-SI58275 KR KOREA,REPUBLIC OF","customerAddress":"NO.15, GOPALAKRISHNAN ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720117800,"product":"ICOSAPENT ETHYL","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"NOVASEP","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED","customerCountry":"INDIA","quantity":"30.34","actualQuantity":"30.338","unit":"KGS","unitRateFc":"448","totalValueFC":"14918","currency":"EUR","unitRateINR":"41104","date":"05-Jul-2024","totalValueINR":"1247012.79","totalValueInUsd":"14918","indian_port":"Bombay Air","hs_no":"29161990","bill_no":"4345948","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"Avenue du Lac, Mourenx - 64150, , FranceSDNF France","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721241000,"product":"ETHYL ICOSAPENTATE(ICOSAPENT ETHYL)","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH","supplierCountry":"TAIWAN","foreign_port":"TAIYUAN","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"24.00","actualQuantity":"24","unit":"KGS","unitRateFc":"200","totalValueFC":"5089","currency":"USD","unitRateINR":"17724.9","date":"18-Jul-2024","totalValueINR":"425397.95","totalValueInUsd":"5089","indian_port":"Bombay Air","hs_no":"29153100","bill_no":"4570234","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIYUAN","supplierAddress":"CH CO , LTD . 1 TUNG-HSING STREET,SHU-LIN-DIST., NEW TAIPEI CITY 23850, TAIWAN R.O.C TAIWAN TAIWAN","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727116200,"product":"ICOSAPENT ETHYL J.P (INV NO. BD091924E97D00E0570 DTD. 19.09.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"M\/S AK BIOPHARM CO LTD","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"570.00","actualQuantity":"570","unit":"KGS","unitRateFc":"120","totalValueFC":"69052","currency":"USD","unitRateINR":"10152","date":"24-Sep-2024","totalValueINR":"5786640","totalValueInUsd":"69052","indian_port":"Bombay Air","hs_no":"29162090","bill_no":"5778026","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"81, SANGGAE-RO, NAM-GU UISAN 44787 REPLUBLIC OF KOREA KR","customerAddress":"407\/408,SHARDA CHAMBERS,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731868200,"product":"ICOSAPENT ETHYL J.P (INV NO. BD111124E97D00E1520 DTD. 11.11.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"M\/S AK BIOPHARM CO LTD","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1520.00","actualQuantity":"1520","unit":"KGS","unitRateFc":"113","totalValueFC":"173615.9","currency":"USD","unitRateINR":"9638.9","date":"18-Nov-2024","totalValueINR":"14651128","totalValueInUsd":"173615.9","indian_port":"Bombay Air","hs_no":"29162090","bill_no":"6733867","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"81, SANGGAE-RO, NAM-GU UISAN 44787 REPLUBLIC OF KOREA KR","customerAddress":"407\/408,SHARDA CHAMBERS,"}]
    15-Jan-2021
    18-Nov-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

    Details:

    Dr Reddy's Laboratories announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market. Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 22, 2021

    Dr Reddy Company Banner

    01

    Dr. Reddy's Laboratories

    India
    arrow
    BioAsia
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

    Details : Dr Reddy's Laboratories announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market. Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.

    Product Name : Undisclosed

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    June 22, 2021

    Dr Reddy Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Strides Launches Icosapent Ethyl Acid Soft Gel Capsules in Partnership with Amneal

    Details:

    Vascepa-Generic (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Amneal Pharmaceuticals

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable December 02, 2023

    Strides Pharma Science

    02

    Strides Pharma Science

    India
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Amneal Pharmaceuticals

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Strides Launches Icosapent Ethyl Acid Soft Gel Capsules in Partnership with Amneal

    Details : Vascepa-Generic (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.

    Product Name : Vascepa-Generic

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    December 02, 2023

    Strides Pharma Science

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Strides Receives USFDA Approval for Icosapent Ethyl Capsules

    Details:

    Icosapent ethyl capsules is an ethyl ester of eicosapentaenoic acid (EPA), which is indicated for the treatment of to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina in adult patients with elevated triglyceride.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 03, 2023

    Strides Pharma Science

    03

    Strides Pharma Science

    India
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Strides Receives USFDA Approval for Icosapent Ethyl Capsules

    Details : Icosapent ethyl capsules is an ethyl ester of eicosapentaenoic acid (EPA), which is indicated for the treatment of to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina in adult patients with elevated trigly...

    Product Name : Vascepa-Generic

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    October 03, 2023

    Strides Pharma Science

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin Partner EddingPharm Gets Approval for VASCEPA® in China for CVRR

    Details:

    Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 08, 2024

    blank

    04

    Edding Pharm

    China
    arrow
    The Generic Rx Session
    Not Confirmed

    Edding Pharm

    China
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Amarin Partner EddingPharm Gets Approval for VASCEPA® in China for CVRR

    Details : Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.

    Product Name : Vascepa

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    July 08, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin Receives National Reimbursement for VAZKEPA® in Greece and Signs Marketing Deal

    Details:

    Under the terms of the agreement, Vianex will be the sole and exclusive distributor of Vazkepa (icosapent ethyl). it is an approved product indicated for the treatment of cardiovascular diseases.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Vianex S.A

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement May 28, 2024

    blank

    05

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Vianex S.A

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Amarin Receives National Reimbursement for VAZKEPA® in Greece and Signs Marketing Deal

    Details : Under the terms of the agreement, Vianex will be the sole and exclusive distributor of Vazkepa (icosapent ethyl). it is an approved product indicated for the treatment of cardiovascular diseases.

    Product Name : Vazkepa

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    May 28, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

    Details:

    Under the agreement, Amneal in-licensed Icosapent ethyl acid soft gel capsules, a product referencing Vascepa and an ethyl ester of eicosapentaenoic acid that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Amneal Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement December 01, 2023

    blank

    06

    Strides Pharma Science

    Country
    arrow
    The Generic Rx Session
    Not Confirmed

    Strides Pharma Science

    Country
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Amneal Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

    Details : Under the agreement, Amneal in-licensed Icosapent ethyl acid soft gel capsules, a product referencing Vascepa and an ethyl ester of eicosapentaenoic acid that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe ...

    Product Name : Vascepa-Generic

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    December 01, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy

    Details:

    Vazkepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable August 09, 2023

    blank

    07

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands a...

    Details : Vazkepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.

    Product Name : Vazkepa

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    August 09, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin and Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel

    Details:

    Under the agreement, Amarin has appointed Neopharm as its sole and exclusive distributor of Vazkepa (icosapent ethyl) approved to reduce the risk of cardiovascular events in adult statin-treated patients at high cardiovascular risk with elevated triglycerides in Israel.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Amarin

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement August 08, 2023

    blank

    08

    Neopharm

    Israel
    arrow
    The Generic Rx Session
    Not Confirmed

    Neopharm

    Israel
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Amarin

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Amarin and Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl)...

    Details : Under the agreement, Amarin has appointed Neopharm as its sole and exclusive distributor of Vazkepa (icosapent ethyl) approved to reduce the risk of cardiovascular events in adult statin-treated patients at high cardiovascular risk with elevated triglyce...

    Product Name : Vazkepa

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    August 08, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

    Details:

    The partnership aims to distribute and commercialize Vazkepa (icosapent ethyl), approved and commercialized in a number of global markets, including the U.S. and European markets, across 10 countries, including nine in Southeast Asia and South Korea.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Lotus Pharmaceutical Industries

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership July 31, 2023

    blank

    09

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Lotus Pharmaceutical Industries

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa...

    Details : The partnership aims to distribute and commercialize Vazkepa (icosapent ethyl), approved and commercialized in a number of global markets, including the U.S. and European markets, across 10 countries, including nine in Southeast Asia and South Korea.

    Product Name : Vazkepa

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    July 31, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amarin Announces Vascepa (icosapent ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)

    Details:

    VASCEPA/VAZKEPA (icosapent ethyl) Capsules first prescription treatment approved by the FDA comprised solely of the active ingredient, icosapent ethyl, a unique form of eicosapentaenoic acid for the treatment of Hypertriglyceridemia and Reduce Cardiovascular Risk.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 21, 2023

    blank

    10

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed

    Amarin

    Ireland
    arrow
    The Generic Rx Session
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Icosapent Ethyl

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Amarin Announces Vascepa (icosapent ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom o...

    Details : VASCEPA/VAZKEPA (icosapent ethyl) Capsules first prescription treatment approved by the FDA comprised solely of the active ingredient, icosapent ethyl, a unique form of eicosapentaenoic acid for the treatment of Hypertriglyceridemia and Reduce Cardiovasc...

    Product Name : Vascepa

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    June 21, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Dr. Reddy's Laboratories

    India
    arrow
    BioAsia
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 1GM

    Packaging :

    Approval Date : 2020-08-07

    Application Number : 209499

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories

    India
    arrow
    BioAsia
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 500MG

    Packaging :

    Approval Date : 2023-03-08

    Application Number : 209499

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Ajanta Pharma Limited

    India
    BioAsia
    Not Confirmed
    arrow

    Ajanta Pharma Limited

    India
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 500MG

    Packaging :

    Approval Date : 2023-12-07

    Application Number : 216811

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Apotex Inc

    Canada
    BioAsia
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 1GM

    Packaging :

    Approval Date : 2021-06-30

    Application Number : 209437

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Bahrain Pharma

    Bahrain
    BioAsia
    Not Confirmed
    arrow

    Bahrain Pharma

    Bahrain
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Bahrain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : Bahrain

    Choline; Eicosapentaenoic Acid; Vinpocetine; Ginkgo biloba L., folium

    Brand Name : Omgobit

    Dosage Form : SYRUP

    Dosage Strength : 150MG; 125MG; 5MG; 60MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : Bahrain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Hikma Pharmaceuticals

    United Kingdom
    BioAsia
    Not Confirmed
    arrow

    Hikma Pharmaceuticals

    United Kingdom
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 500MG

    Packaging :

    Approval Date : 2023-03-08

    Application Number : 209457

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Madras Pharmaceuticals

    India
    BioAsia
    Not Confirmed
    arrow

    Madras Pharmaceuticals

    India
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Fish Oil; Eicosapentaenoic Acid; Docosahexaenoic Acids

    Brand Name :

    Dosage Form : Softgelatin Capsule

    Dosage Strength : 1000MG; 465MG; 375MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ORIFARM GROUP AS

    Denmark
    BioAsia
    Not Confirmed
    arrow

    ORIFARM GROUP AS

    Denmark
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Ikosapentetyl

    Brand Name : Vazkepa

    Dosage Form : Kapsel, myk

    Dosage Strength : 998 mg

    Packaging : Boks 120item

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Zydus Lifesciences

    India
    BioAsia
    Not Confirmed
    arrow

    Zydus Lifesciences

    India
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 500MG

    Packaging :

    Approval Date : 2023-04-20

    Application Number : 217656

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Country
    BioAsia
    Not Confirmed
    arrow

    Country
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ICOSAPENT ETHYL

    Brand Name : ICOSAPENT ETHYL

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 1GM

    Packaging :

    Approval Date : 2023-09-22

    Application Number : 217844

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Parenteral

    read-more
    read-more

    01

    EUROAPI

    France
    arrow
    NextGen Biomed
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral

    Grade : Topical, Parenteral

    Category : Parenteral, Topical

    Brand Name : Purified Glycerin

    Application : Parenteral, Topical

    Excipient Details : Purified glycerin is used in topical dosage forms such as creams, lotions, and ointments. It is also used as a solvent in parenteral formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Glycerin Excipient

    arrow
    ERUOAPI Purified Glycerin

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Polysorbate 80

    Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Polysorbate 80

    arrow
    Polysorbate 80

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Pfanstiehl

    U.S.A
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Category : Parenteral, Thickeners and Stabilizers

    Brand Name : Sucrose

    Application : Parenteral, Thickeners and Stabilizers

    Excipient Details : Sucrose is used to stabilize proteins, lipids, carbohydrates, ADCs & vaccines. It is also used as a cryopreservative in cell-based bioprocesses.

    Pharmacopoeia Ref : USDMF, NF, EP, JP, ChP

    Technical Specs : N/A

    Ingredient(s) : Sucrose

    arrow
    Pfanstiehl Sucrose

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    Pluviaendo

    Turkey
    BioAsia
    Not Confirmed
    arrow

    05

    Nanjing Well Pharmaceutical

    China
    arrow
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASK US

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Emulsion, Injectable / Parenteral

    Grade : Parenteral

    Category : Emulsifying Agents, Parenteral, Solubilizers

    Brand Name : Soybean Lecithin

    Application : Emulsifying Agents, Parenteral, Solubilizers

    Excipient Details : Soya lecithin is used as solubilizer & emulsifier in parenteral dosage forms such as fat emulsion injections, mixed micelle preparations & emulsions.

    Pharmacopoeia Ref : ChP/EP

    Technical Specs : NA

    Ingredient(s) : Soya Lecithin

    arrow
    Nanjing well

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Nanjing Well Pharmaceutical

    China
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Propylene Glycol

    Application : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical

    Excipient Details : Propylene glycol is used as a solvent & stabilizer in injections. It is also used in topical semi-solids & as a plasticizer in soft capsules.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Propylene Glycol

    arrow
    Nanjing Well Propylene Glycol

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    07

    Nanjing Well Pharmaceutical

    China
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Category : Parenteral

    Brand Name : Soybean Oil

    Application : Parenteral

    Excipient Details : Soybean oil is used as a solvent for common and complex injections.

    Pharmacopoeia Ref : Chp/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Soybean Oil

    arrow
    Soybean Oil

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Finar

    India
    BioAsia
    Not Confirmed
    arrow

    09

    Nanjing Bold Chemical

    China
    BioAsia
    Not Confirmed
    arrow

    10

    Roquette

    France
    BioAsia
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Fillers, Diluents & Binders

    read-more
    read-more

    01

    EUROAPI

    France
    arrow
    NextGen Biomed
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Dosage Form : Tablet

    Grade : Oral

    Category : Fillers, Diluents & Binders

    Brand Name : Calcium Lactate-Glycerol Adduct

    Application : Fillers, Diluents & Binders

    Excipient Details : Calcium lactate-glycerol adduct is used both as a stabilizer and a binder in tablet formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Calcium Lactate

    arrow
    EUROAPI Calcium Lactate-Glycerol Adduct

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Rochem International Inc

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.0F117
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Brand Name : Xylitol

    Application : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders

    Excipient Details : Xylitol is used as filler, binder & a coating agent in various oral dosage forms in both pharmaceutical and nutraceutical applications.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Xylitol Excipient

    arrow
    Xylitol

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    SPI Pharma

    U.S.A
    arrow
    DCAT Week
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Brand Name : Compressol SM

    Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking

    Excipient Details : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, low disintegration time & hygroscopicity.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Mannitol

    arrow
    Compressol SM

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : GELATIN BOVINE 140B 6M

    Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : Gelatin bovine 140B 6M is used as a stabilizer in parenteral drug products and as a binder and filler in capsules, tablets, granules, and pellets.

    Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Gelatin Excipient

    arrow
    GELATIN BOVINE 140B 6M

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : GELITA

    Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : Gelita RXL R² 115B BB TB Ph is used as a stabilizer in parenteral formulations and as a filler and binder in tablets, capsules, granules, and pellets.

    Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Gelatin Excipient

    arrow
    GELITA

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : PIG SKIN GELATIN 100B 20M

    Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : Pig skin gelatin 100B 20M is used as a filler and binder in capsules, tablets, pellets, and granules and as a stabilizer in parenteral formulations.

    Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Gelatin Excipient

    arrow
    PIG SKIN GELATIN 100B 20M

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    07

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : PIG SKIN GELATIN 140B 20M

    Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : Pig skin gelatin 140B 20M is used as a binder and filler in pellets, granules, capsules, and tablets and as a stabilizer in parenteral products.

    Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Gelatin Excipient

    arrow
    PIG SKIN GELATIN 140B 20M

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Zhejiang Huakang Pharmaceutical

    China
    The Generic Rx Session
    Not Confirmed
    arrow

    09

    Sigachi Industries

    India
    The Generic Rx Session
    Not Confirmed
    arrow

    10

    Roquette

    France
    The Generic Rx Session
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Film Formers & Plasticizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Soft Gelatin

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US
    Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US

    20 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218899

    FDA
    20 Nov 2024
    Share Share
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978267/18362/en/Investigators-to-Present-New-REDUCE-IT-Subanalysis-of-VASCEPA-VAZKEPA-icosapent-ethyl-in-Patients-With-and-Without-Coronary-Artery-Disease-History-and-Mechanistic-Data-on-Eicosapen.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share
    Research On VASCEPA To Be Presented At EASD Meeting
    Research On VASCEPA To Be Presented At EASD Meeting

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942721/18362/en/Research-Highlighting-the-Clinical-Impact-of-VASCEPA-VAZKEPA-icosapent-ethyl-in-Patients-with-Diabetes-and-High-Cardiovascular-Risk-and-the-Anti-Lp-a-Oxidation-Mechanistic-Effect-o.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    Amarin's VAZKEPA Gets National Reimbursement In Portugal
    Amarin's VAZKEPA Gets National Reimbursement In Portugal

    17 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/17/2914903/18362/en/Amarin-Receives-National-Reimbursement-for-VAZKEPA-icosapent-ethyl-in-Portugal.html

    GLOBENEWSWIRE
    17 Jul 2024
    Share Share
    Amarin's Partner Gets China Approval For VASCEPA In Cardiovascular Risk
    Amarin's Partner Gets China Approval For VASCEPA In Cardiovascular Risk

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909539/18362/en/Amarin-Partner-EddingPharm-Receives-Regulatory-Approval-for-VASCEPA-Icosapent-Ethyl-in-Mainland-China-for-Cardiovascular-Risk-Reduction-CVRR.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit
    Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit

    18 Jun 2024

    // REUTERS

    https://www.reuters.com/legal/litigation/drugmaker-apotex-accuses-amarin-vascepa-monopoly-us-lawsuit-2024-06-17/

    REUTERS
    18 Jun 2024
    Share Share

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    india-flag.png
    Eicosapentaenoic Acid (10 kg) API needed in India [ENA18618]
    A company that deals in various pharmaceutical products is looking for suppliers of Eicosapentaenoic Acid (10 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.
    15 Nov 2023

    Reply

    15 Nov 2023

    Reply text-arrow

    Reply Comment (3)

    15 Nov 2023

    india-flag.png
    Icosapent Ethyl (MOQ) API needed in India [ENA18052]
    A company that focuses on research, development and manufacturing of soft gel capsules is looking for suppliers of Icosapent Ethyl (MOQ) API for commercial purposes. The suppliers must support this enquiry with CoA.
    16 Sep 2023

    Reply

    16 Sep 2023

    Reply text-arrow

    Reply Comment (4)

    16 Sep 2023

    india-flag.png
    Eicosapentaenoic Acid (25 kg) API needed in India [ENA17910]
    A company that focuses on the manufacturing of OSDs, gels, creams & lotions is looking for suppliers of Eicosapentaenoic Acid (25 kg) API for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    29 Aug 2023

    Reply

    29 Aug 2023

    Reply text-arrow

    Reply Comment (2)

    29 Aug 2023

    Egypt.png
    Icosapent Ethyl (1.2 MT) API needed in Egypt [ENA17458]
    A company that focuses on the manufacturing, sales, marketing activities, import & export activities and distribution of pharmaceuticals is looking for suppliers of Icosapent Ethyl (1.2 MT) API for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    04 Jul 2023

    Reply

    04 Jul 2023

    Reply text-arrow

    Reply Comment (9)

    04 Jul 2023

    india-flag.png
    Icosapent Ethyl (96%) API needed in India [ENA17376]
    A company that focuses on the development of innovative medicines is looking for suppliers of Icosapent Ethyl (96%) API for development purposes. The suppliers must support this enquiry with CEP, open part DMF & CoA.
    22 Jun 2023

    Reply

    22 Jun 2023

    Reply text-arrow

    Reply Comment (0)

    22 Jun 2023

    india-flag.png
    Eicosapentaenoic Acid API needed in India [ENA16539]
    A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Eicosapentaenoic Acid API for commercial purposes. The suppliers must support this enquiry with CoA.
    06 Mar 2023

    Reply

    06 Mar 2023

    Reply text-arrow

    Reply Comment (3)

    06 Mar 2023

    Bangladesh.png
    Icosapent Ethyl API needed in Bangladesh [ENA14788]
    A company that focuses on manufacturing a range of finished formulations is looking for suppliers of Icosapent Ethyl API for development purpose. The suppliers must support this enquiry with open part DMF & CoA.
    23 Aug 2022

    Reply

    23 Aug 2022

    Reply text-arrow

    Reply Comment (4)

    23 Aug 2022

    Bangladesh.png
    USP Grade Icosapent Ethyl API needed in Bangladesh [ENA13785]
    A company that deals in various pharmaceutical products is looking for suppliers of USP Grade Icosapent Ethyl API for commercial purpose. The suppliers must support this enquiry with GMP.
    28 May 2022

    Reply

    28 May 2022

    Reply text-arrow

    Reply Comment (6)

    28 May 2022

    Bangladesh.png
    Icosapent Ethyl API needed in Bangladesh [ENA12673]
    A company that deals in the trading of various pharmaceutical products is looking for suppliers of Icosapent Ethyl API for commercial purpose. The suppliers must support this enquiry with CoA.
    11 Feb 2022

    Reply

    11 Feb 2022

    Reply text-arrow

    Reply Comment (7)

    11 Feb 2022

    United_States_of_America.png
    Icosapent Ethyl API needed in the United States [ENA12426]
    A company that provides consultancy services to the pharmaceutical industry in the area of formulation and process development is looking for suppliers of Icosapent Ethyl API for both development & commercial purpose. The suppliers must support this enquiry with USDMF, USFDA & CoA.
    17 Jan 2022

    Reply

    17 Jan 2022

    Reply text-arrow

    Reply Comment (7)

    17 Jan 2022

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Looking for 10417-94-4 / Icosapent Ethyl API manufacturers, exporters & distributors?

    Icosapent Ethyl manufacturers, exporters & distributors 1

    66

    PharmaCompass offers a list of Icosapent Ethyl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icosapent Ethyl manufacturer or Icosapent Ethyl supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icosapent Ethyl manufacturer or Icosapent Ethyl supplier.

    PharmaCompass also assists you with knowing the Icosapent Ethyl API Price utilized in the formulation of products. Icosapent Ethyl API Price is not always fixed or binding as the Icosapent Ethyl Price is obtained through a variety of data sources. The Icosapent Ethyl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Icosapent Ethyl

    Synonyms

    Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, Epa, Cis-5,8,11,14,17-eicosapentaenoic acid

    Cas Number

    10417-94-4

    Unique Ingredient Identifier (UNII)

    AAN7QOV9EA

    About Icosapent Ethyl

    Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.

    Icosapent Manufacturers

    A Icosapent manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icosapent, including repackagers and relabelers. The FDA regulates Icosapent manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icosapent API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Icosapent manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Icosapent Suppliers

    A Icosapent supplier is an individual or a company that provides Icosapent active pharmaceutical ingredient (API) or Icosapent finished formulations upon request. The Icosapent suppliers may include Icosapent API manufacturers, exporters, distributors and traders.

    click here to find a list of Icosapent suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Icosapent USDMF

    A Icosapent DMF (Drug Master File) is a document detailing the whole manufacturing process of Icosapent active pharmaceutical ingredient (API) in detail. Different forms of Icosapent DMFs exist exist since differing nations have different regulations, such as Icosapent USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Icosapent DMF submitted to regulatory agencies in the US is known as a USDMF. Icosapent USDMF includes data on Icosapent's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Icosapent USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Icosapent suppliers with USDMF on PharmaCompass.

    Icosapent JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The Icosapent Drug Master File in Japan (Icosapent JDMF) empowers Icosapent API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the Icosapent JDMF during the approval evaluation for pharmaceutical products. At the time of Icosapent JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of Icosapent suppliers with JDMF on PharmaCompass.

    Icosapent KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Icosapent Drug Master File in Korea (Icosapent KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Icosapent. The MFDS reviews the Icosapent KDMF as part of the drug registration process and uses the information provided in the Icosapent KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Icosapent KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Icosapent API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Icosapent suppliers with KDMF on PharmaCompass.

    Icosapent GMP

    Icosapent Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Icosapent GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Icosapent GMP manufacturer or Icosapent GMP API supplier for your needs.

    Icosapent CoA

    A Icosapent CoA (Certificate of Analysis) is a formal document that attests to Icosapent's compliance with Icosapent specifications and serves as a tool for batch-level quality control.

    Icosapent CoA mostly includes findings from lab analyses of a specific batch. For each Icosapent CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Icosapent may be tested according to a variety of international standards, such as European Pharmacopoeia (Icosapent EP), Icosapent JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Icosapent USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search